Health on MSN2d
This Test May Be a Better Indicator of Heart Disease Risk Than a Standard Cholesterol Panel
A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.
Clinical trial finds RNA inhibitor effectively reduces 'bad cholesterol' in patients with cardiovascular disease
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
EurekAlert!3d
An RNA inhibitor may effectively reduce a high-risk type of cholesterol in patients with cardiovascular disease
Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...
Rolling Out1d
7 surprising ApoB truths about heart health risks
ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of ...
News Medical on MSN1d
Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
Armed robbery in Revesby2d
RNA Inhibitor Reduces High-Risk Cholesterol in CVD
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Armed robbery in Revesby2d
RNA Inhibitor May Cut High-Risk Cholesterol in Patients
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according ...
News Medical on MSN3d
Adverse pregnancy outcomes increase cardiovascular risk, even in unaffected sisters
A study reveals that women with adverse pregnancy outcomes and their APO-free sisters share elevated cardiovascular disease risks, indicating genetic links.
Monthly Prescribing Reference3d
Novel PCSK9 Inhibitor Lerodalcibep Under Review for Patients Requiring LDL-C Reduction
Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.
'I'm a professor - here's a common cholesterol-lowering mistake that can make matters worse'
According to a professor from ZOE - you know you do not have to eliminate fat completely and can lower your bad cholesterol ...
Nottinghamshire Live on MSN5d
Professor warns of cholesterol mistake which usually 'makes things worse'
She corrects the widespread misconception, claiming that eradicating fat to reduce cholesterol is "nonsense." Contrary to ...
The common cholesterol mistake a professor has warned could 'make things worse'
Cholesterol is a fatty substances which collects in our blood vessels, and is caused by things like diet, exercise, and ...